Rallybio Corporation logo

Rallybio Corporation

NASDAQ:RLYB

Overview | Financials
Company Name Rallybio Corporation
Symbol RLYB
Currency USD
Price 0.95
Market Cap 39,413,220
Dividend Yield 0%
52-week-range 0.93 - 3.46
Industry Biotechnology
Sector Healthcare
CEO Dr. Stephen Uden M.B, M.D.
Website https://www.rallybio.com

An error occurred while fetching data.

About Rallybio Corporation

Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of fetal and neonatal

Related Stocks

Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc.

PRAX

76.52 USD

Adicet Bio, Inc. logo

Adicet Bio, Inc.

ACET

0.91 USD

Day One Biopharmaceuticals, Inc. logo

Day One Biopharmaceuticals, Inc.

DAWN

12.79 USD

Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd.

DRTS

3.1 USD

Vaxart, Inc. logo

Vaxart, Inc.

VXRT

0.62 USD

Kinnate Biopharma Inc. logo

Kinnate Biopharma Inc.

KNTE

2.65 USD

CareMax, Inc. logo

CareMax, Inc.

CMAX

0.422 USD

Bionano Genomics, Inc. logo

Bionano Genomics, Inc.

BNGO

0.195 USD

IRadimed Corporation logo

IRadimed Corporation

IRMD

54.65 USD

Financials

Numbers are in millions USD

Numbers are in millions USD